Syneron Appoints Dominick Arena to Its Board of Directors
March 13 2012 - 9:00AM
Marketwired
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic
device company, announced today that Dominick Arena has been
appointed to the Company's Board of Directors effective as of March
5, 2012. Mr. Arena has over 30 years of experience in the
healthcare industry leading companies of various sizes and stages
of development, from start-ups to large multinational companies. He
replaces Jerry Puorro, who recently retired from the Board of
Directors. Mr. Puorro was President and Chief Executive Officer of
Candela Corporation prior to its acquisition by Syneron in January
2010. Following the appointment of Mr. Arena, Syneron continues to
have six independent directors and one non-independent director.
Dr. Shimon Eckhouse, Co-founder and Chairman of the Board of
Directors of Syneron Medical, said, "We are pleased to welcome
Dominick Arena to the Syneron Board of Directors. Dominick has a
proven track record as an executive in the healthcare industry,
including a wide array of relevant experience that will benefit
Syneron. This includes his current positions, which focus on
providing strategic guidance in operational management, mergers and
acquisitions, and developing and executing growth strategies. We
look forward to working with Dominick as we continue to strive to
enhance the value of the Company for our shareholders."
Dr. Eckhouse added, "On behalf of the Board of Directors, I
would like to thank Jerry Puorro for his service on the Board. We
benefitted from Jerry's strong industry experience and his
significant contributions during the Candela integration process.
We wish him the best in his other endeavors."
Mr. Arena currently serves as an operating partner with Water
Street Healthcare Partners, a strategic private equity firm focused
exclusively on the healthcare industry. Previously, Mr. Arena was
President of Smiths Critical Care, a division of Smiths Medical. He
joined Smiths Medical after the company acquired Medex Inc., where
he served as President and Chief Executive Officer. Prior to this,
Mr. Arena led the Healthcare division of the Furon Company, and
served as the leader of three medical device manufacturers: AnaMed
International, Hudson Respiratory Care, and Respiratory Care, Inc.
He also previously held positions at The Kendall Corporation and
Baxter International Inc. Mr. Arena currently serves on the Boards
of Directors of Sigma International, US Endoscopy, and The Legacy
Foundation. He previously served on the Boards of Alpine Biomed and
Facet Technologies. Mr. Arena received a Bachelors of Science in
Chemistry from Le Moyne College.
About Syneron Medical Ltd. Syneron Medical
Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company
with a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide
advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, rejuvenation of the skin's appearance through the
treatment of superficial benign vascular and pigmented lesions, and
the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel.
Syneron also has R&D and manufacturing operations in the US.
The Company markets, services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy,
Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and
distributors worldwide.
Investor Contacts: Asaf Alperovitz Chief Financial
Officer + 972 73 244 2283 Email: Email Contact Zack Kubow The Ruth
Group 646-536-7020 Email: Email Contact
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Historical Stock Chart
From Apr 2024 to May 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Historical Stock Chart
From May 2023 to May 2024